These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 25813519)

  • 41. Comparative study of the sensitivity of lymphoblastoid and transformed monocytic cell lines to the cytotoxic effects of Viscum album extracts of different origin.
    Duong Van Huyen JP; Delignat S; Kazatchkine MD; Kaveri SV
    Chemotherapy; 2003 Dec; 49(6):298-302. PubMed ID: 14671430
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization and antiglycation activity of phenolic constituents from Viscum album (European Mistletoe).
    Choudhary MI; Maher S; Begum A; Abbaskhan A; Ali S; Khan A; ;
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):980-2. PubMed ID: 20606351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Component Composition and Features of Biological Activity of Viscum album (Viscaceae).
    Adzhiakhmetova SL; Chervonnaya NM; Pozdnyakov DI; Popova OI; Oganisyan ET
    Dokl Biol Sci; 2024 Oct; 518(1):116-132. PubMed ID: 39128961
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive Metabolome Analysis of Fermented Aqueous Extracts of
    Peñaloza E; Holandino C; Scherr C; Araujo PIP; Borges RM; Urech K; Baumgartner S; Garrett R
    Molecules; 2020 Sep; 25(17):. PubMed ID: 32887375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viscum Album in the Treatment of a Girl With Refractory Childhood Absence Epilepsy.
    von Schoen-Angerer T; Madeleyn R; Kienle G; Kiene H; Vagedes J
    J Child Neurol; 2015 Jul; 30(8):1048-52. PubMed ID: 25038133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety of higher dosages of Viscum album L. in animals and humans--systematic review of immune changes and safety parameters.
    Kienle GS; Grugel R; Kiene H
    BMC Complement Altern Med; 2011 Aug; 11():72. PubMed ID: 21871125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An overview on anticancer activities of the Viscum album extract Isorel.
    Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
    Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteomic fingerprinting of mistletoe (Viscum album L.) via combinatorial peptide ligand libraries and mass spectrometry analysis.
    Vergara-Barberán M; Lerma-García MJ; Nicoletti M; Simó-Alfonso EF; Herrero-Martínez JM; Fasoli E; Righetti PG
    J Proteomics; 2017 Jul; 164():52-58. PubMed ID: 28571969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant Cancer Biotherapy by Viscum Album Extract Isorel: Overview of Evidence Based Medicine Findings.
    Sunjic SB; Gasparovic AC; Vukovic T; Weiss T; Weiss ES; Soldo I; Djakovic N; Zarkovic T; Zarkovic N
    Coll Antropol; 2015 Sep; 39(3):701-8. PubMed ID: 26898069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antihypercholesterolaemic and antioxidant activity assessment of some plants used as remedy in Turkish folk medicine.
    Avci G; Kupeli E; Eryavuz A; Yesilada E; Kucukkurt I
    J Ethnopharmacol; 2006 Oct; 107(3):418-23. PubMed ID: 16713156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma.
    Mabed M; El-Helw L; Shamaa S
    Br J Cancer; 2004 Jan; 90(1):65-9. PubMed ID: 14710208
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunostimulatory properties of mistletoe extracts and their application in oncology].
    Wrotek S; Skawiński R; Kozak W
    Postepy Hig Med Dosw (Online); 2014 Oct; 68():1216-24. PubMed ID: 25380204
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel GHB-derived natural products from European mistletoe (Viscum album).
    Amer B; Juvik OJ; Francis GW; Fossen T
    Pharm Biol; 2013 Aug; 51(8):981-6. PubMed ID: 23734579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of European mistletoe (Viscum album L. subsp. album) extracts on activity rhythms of the Syrian hamsters (Mesocricetus auratus).
    Karakas A; Turker AU; Gunduz B
    Nat Prod Res; 2008; 22(11):990-1000. PubMed ID: 18629716
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
    Büssing A; Schietzel M
    Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory and antinociceptive activity of flavonoids isolated from Viscum album ssp. album.
    Orhan DD; Küpeli E; Yesilada E; Ergun F
    Z Naturforsch C J Biosci; 2006; 61(1-2):26-30. PubMed ID: 16610212
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seasonal variations of triterpene acid contents in Viscum album L. on typical host trees of Hyrcanian forests.
    Soursouri A; Hosseini SM; Fattahi F
    Sci Rep; 2023 Jul; 13(1):11587. PubMed ID: 37463985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of extracts from mistletoe (Viscum album) for herb-drug interaction by inhibition and induction of cytochrome P450 activities.
    Doehmer J; Eisenbraun J
    Phytother Res; 2012 Jan; 26(1):11-7. PubMed ID: 21538623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.